Laboratorija - BIOHEMIJSKI TUMOR-MARKERI BIOCHEMICAL TUMOUR-MARKERS *srb* Tumorski markeri su specifični biomolekuli koje stvara organizam kao metabolički ili imunološki odgovor zdrave ćelije na prisutnost maligne ćelije ili ih produkuju same maligne ...
![PDF) Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies PDF) Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies](https://www.researchgate.net/profile/Esaki-Muthu-Shankar/publication/51431045/figure/tbl1/AS:601654453862407@1520457008233/Alpha-fetoprotein-positivity-profile-in-hepatocellular-carcinoma-cases-N-142_Q320.jpg)
PDF) Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies
![Tumour biomarkers: association with heart failure outcomes - Shi - 2020 - Journal of Internal Medicine - Wiley Online Library Tumour biomarkers: association with heart failure outcomes - Shi - 2020 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d8c29b76-852d-40fa-95c9-3169593c0865/joim13053-toc-0001-m.jpg)
Tumour biomarkers: association with heart failure outcomes - Shi - 2020 - Journal of Internal Medicine - Wiley Online Library
![Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases](https://f6publishing.blob.core.windows.net/850a7c84-f748-4a79-8158-3d67696ca7ca/WJH-12-1046-g001.png)
Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases
![α-Fetoprotein mRNA in situ hybridisation is a highly specific marker of hepatocellular carcinoma: a multi-centre study | British Journal of Cancer α-Fetoprotein mRNA in situ hybridisation is a highly specific marker of hepatocellular carcinoma: a multi-centre study | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-021-01363-4/MediaObjects/41416_2021_1363_Fig1_HTML.png)
α-Fetoprotein mRNA in situ hybridisation is a highly specific marker of hepatocellular carcinoma: a multi-centre study | British Journal of Cancer
![The Innovation | Medicine on Twitter: "Commonly used Tumor Markers A tumor marker is a biomarker found in blood, urine, or body tissues that can be elevated by the presence of one The Innovation | Medicine on Twitter: "Commonly used Tumor Markers A tumor marker is a biomarker found in blood, urine, or body tissues that can be elevated by the presence of one](https://pbs.twimg.com/media/FdDwvxeXgAMJJDi.jpg)
The Innovation | Medicine on Twitter: "Commonly used Tumor Markers A tumor marker is a biomarker found in blood, urine, or body tissues that can be elevated by the presence of one
![AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway | Cell Death & Disease AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-020-03030-7/MediaObjects/41419_2020_3030_Fig1_HTML.png)
AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway | Cell Death & Disease
![Trajectories of serum α-fetoprotein and intermediate-stage hepatocellular carcinoma outcomes after transarterial chemoembolization: A longitudinal, retrospective, multicentre, cohort study - eClinicalMedicine Trajectories of serum α-fetoprotein and intermediate-stage hepatocellular carcinoma outcomes after transarterial chemoembolization: A longitudinal, retrospective, multicentre, cohort study - eClinicalMedicine](https://www.thelancet.com/cms/asset/20cdeb92-3302-416d-a053-937702b7b85a/gr1.jpg)
Trajectories of serum α-fetoprotein and intermediate-stage hepatocellular carcinoma outcomes after transarterial chemoembolization: A longitudinal, retrospective, multicentre, cohort study - eClinicalMedicine
![Cancers | Free Full-Text | Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma Cancers | Free Full-Text | Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma](https://www.mdpi.com/cancers/cancers-13-04765/article_deploy/html/images/cancers-13-04765-g001.png)